Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19
Mohammed Talaat Rashid, Waleed Askar, Ahmed Gaafar, Mohamed Fawzy, Mahmoud Abul Makarem
DOI: 10.5455/medscience.2020.05.084 · Page: 1097-9 · 50 Views · 0 Downloads · 0 Citations
Abstract
Abstract
COVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlying hypercoagulable state), raising questions about appropriate evaluations and interventions to prevent or treat thrombosis. Hypercoagulable state associated with COVID-19 has been repeatedly reported. The prevalence of venous thromboembolism is increasing, especially in the critically ill patient in spite of prophylactic use of anticoagulation. [1-3]. Arterial thrombosis has also been reported but the prevalence is not known. [3]. In this case report, we present a 37 years old man who suffered an acute abdomen due to superior mesenteric artery thrombosis as a possible complication of the COVID-19.
Key words: COVID-19, Superior mesenteric artery thrombosis, acute abdomen, hypercoagulability
Keywords : COVID-19; Superior mesenteric artery thrombosis; acute abdomen; hypercoagulability